Assignee
IDUN PHARMACEUTICALS INC
US·34 granted patents·9 pending applications·526 citations·filing 1996–2005
Top patents by PatentIndex Score
43 records- 0189US6762045B2Membrane derived caspase-3, compositions comprising the same and methods of use thereforIDUN PHARMACEUTICALS INC·Filed 2002·Granted Jul 13, 2004·33 cites·21 claims
- 0289US6200969B1Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 1997·Granted Mar 13, 2001·38 cites·23 claims
- 0383US6197750B1C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 1998·Granted Mar 6, 2001·60 cites·20 claims
- 0483US6184244B1C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 1999·Granted Feb 6, 2001·46 cites·15 claims
- 0582US7183260B2C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2004·Granted Feb 27, 2007·17 cites·54 claims
- 0681US6693096B2Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2002·Granted Feb 17, 2004·11 cites·18 claims
- 0780US6544951B2C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2000·Granted Apr 8, 2003·14 cites·104 claims
- 0879US5869519AC-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 1996·Granted Feb 9, 1999·56 cites·59 claims
- 0978US6270980B1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 1997·Granted Aug 7, 2001·36 cites·15 claims
- 1076US6187771B1Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymesIDUN PHARMACEUTICALS INC·Filed 1999·Granted Feb 13, 2001·31 cites·27 claims
- 1175US5786173AMCH4 and MCH5, apoptotic protease, nucleic acids encoding and methods of useIDUN PHARMACEUTICALS INC·Filed 1996·Granted Jul 28, 1998·26 cites·31 claims
- 1273US6790989B2Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted Sep 14, 2004·8 cites·25 claims
- 1373US6525024B1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted Feb 25, 2003·6 cites·43 claims
- 1472US7053056B2C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted May 30, 2006·6 cites·130 claims
- 1572US6610683B2Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2001·Granted Aug 26, 2003·4 cites·9 claims
- 1672US6528506B2Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2002·Granted Mar 4, 2003·4 cites·7 claims
- 1771US6251614B1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 1999·Granted Jun 26, 2001·25 cites·6 claims
- 1870US6531467B2Inhibition of inflammation using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2001·Granted Mar 11, 2003·5 cites·77 claims
- 1969US6515173B1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2000·Granted Feb 4, 2003·5 cites·24 claims
- 2066US5968927ATricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymesIDUN PHARMACEUTICALS INC·Filed 1997·Granted Oct 19, 1999·19 cites·48 claims
- 2164US6730779B2Antibody that specifically binds an Mch4 polypeptideIDUN PHARMACEUTICALS INC·Filed 2001·Granted May 4, 2004·1 cites·3 claims
- 2264US6489353B2C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2000·Granted Dec 3, 2002·1 cites·41 claims
- 2363US6444663B2Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymesIDUN PHARMACEUTICALS INC·Filed 2000·Granted Sep 3, 2002·1 cites·1 claims
- 2463US5990137AMethod of inhibiting NADPH oxidaseIDUN PHARMACEUTICALS INC·Filed 1998·Granted Nov 23, 1999·21 cites·33 claims
- 2562US6716960B2Mch3, a novel apoptotic protease, nucleic acids encoding and methods of useIDUN PHARMACEUTICALS INC·Filed 2003·Granted Apr 6, 2004·0 cites·3 claims
- 2660US2003060416A1Blk genes, gene products and uses thereof in apoptosisIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 2758US5939460AMethod of inhibiting NADPH oxidaseIDUN PHARMACEUTICALS INC·Filed 1996·Granted Aug 17, 1999·16 cites·3 claims
- 2857US7157430B2(Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2001·Granted Jan 2, 2007·1 cites·2 claims
- 2956US6824991B2Human bad polypeptides, encoding nucleic acids and methods of useIDUN PHARMACEUTICALS INC·Filed 2001·Granted Nov 30, 2004·0 cites·8 claims
- 3056US5851815AMCH4 and MCH5, apoptotic proteasesIDUN PHARMACEUTICALS INC·Filed 1996·Granted Dec 22, 1998·17 cites·8 claims
- 3155US6969703B2Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2002·Granted Nov 29, 2005·1 cites·42 claims
- 3253US2004058850A1Treatment of kidney disease or renal failure using interleukin-1beta-converting enzyme (ICE)/CED-3 family inhibitorsIDUN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 3352US2005065093A1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3451US6391575B1Methods for detecting membrane derived caspase activity and modulators thereofIDUN PHARMACEUTICALS INC·Filed 1999·Granted May 21, 2002·12 cites·13 claims
- 3551US2006084613A1Inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3651US2003119748A1C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3750US2003092072A1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3850US2002197702A1Membrane derived caspase-3, compositions comprising the same and methods of use thereforIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 3946US2002090666A1Methods for detecting membrane derived caspase activity and modulators thereofIDUN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 4043US2003232788A1(Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteasesIDUN PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 4140US6518032B1Rapid methods for identifying modifiers of cellular apoptosis activityIDUN PHARMACEUTICALS INC·Filed 1999·Granted Feb 11, 2003·5 cites·32 claims
- 4234US6686459B1Mch3, a novel apoptotic protease, nucleic acids encoding and methods of useIDUN PHARMACEUTICALS INC·Filed 1998·Granted Feb 3, 2004·0 cites·7 claims
- 4329US6504022B1Human bad polypeptides, encoding nucleic acids and methods of useIDUN PHARMACEUTICALS INC·Filed 1999·Granted Jan 7, 2003·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when IDUN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →